Louisbourg Investments Trims Johnson & Johnson Stake

The investment firm reduced its holdings in the pharmaceutical giant by 16.8% in Q4 2025.

Apr. 6, 2026 at 9:09am

Got story updates? Submit your updates here. ›

Louisbourg Investments Inc. decreased its holdings in Johnson & Johnson (NYSE:JNJ) by 16.8% in the fourth quarter of 2025, according to the company's latest 13F filing with the SEC. The fund now owns 32,912 shares of the company's stock, valued at $6.81 million, making it the 26th largest position in Louisbourg's investment portfolio.

Why it matters

This filing provides insight into the investment decisions of Louisbourg Investments, a prominent institutional investor. The reduction in Johnson & Johnson holdings could signal a shift in the firm's outlook on the pharmaceutical company or broader market trends.

The details

Louisbourg Investments sold 6,660 shares of Johnson & Johnson stock during the fourth quarter, bringing its total holdings down to 32,912 shares. The firm's position in JNJ now makes up about 1.3% of its overall investment portfolio.

  • Louisbourg Investments filed the 13F report for the fourth quarter of 2025.

The players

Louisbourg Investments Inc.

An investment management firm that oversees a diversified portfolio of stocks, bonds, and other assets.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the evolving investment strategies of major institutional players like Louisbourg Investments, which could signal broader market trends or changes in sentiment around specific companies like Johnson & Johnson.